VeriMomp-cresyl isovalerate hamilelikte güvenli mi?
No EU Annex II/III listing or harmonised CLP reproductive classification found; no SCCS or CIR safety opinion specifically for p‑cresyl isovalerate. JECFA evaluated p‑cresyl isovalerate (p‑tolyl isovalerate) as a flavouring and concluded 'no safety concern at current levels of intake' (2000). ECHA substance record shows REACH registration but no harmonised reproductive hazard classification; supplier SDSs report acute oral hazard statements (H302) but not H360/H361. Given the absence of reproductive or developmental toxicity evidence, hazard (h) and mechanism (m) are scored 0; dermal absorption from a small lipophilic ester used as a fragrance is likely low but measurable, so exposure (e) = 1. Sources: ECHA substance record, JECFA, PubChem/supplier pages, EWG listing.
Related ingredients
Frequently asked questions
- p-cresyl isovalerate hamilelikte güvenli mi?
- No EU Annex II/III listing or harmonised CLP reproductive classification found; no SCCS or CIR safety opinion specifically for p‑cresyl isovalerate. JECFA evaluated p‑cresyl isovalerate (p‑tolyl isovalerate) as a flavouring and concluded 'no safety concern at current levels of intake' (2000). ECHA substance record shows REACH registration but no harmonised reproductive hazard classification; supplier SDSs report acute oral hazard statements (H302) but not H360/H361. Given the absence of reproductive or developmental toxicity evidence, hazard (h) and mechanism (m) are scored 0; dermal absorption from a small lipophilic ester used as a fragrance is likely low but measurable, so exposure (e) = 1. Sources: ECHA substance record, JECFA, PubChem/supplier pages, EWG listing.
- p-cresyl isovalerate emzirirken güvenli mi?
- Same evidence base as pregnancy: no harmonised CMR classification or reproductive/developmental studies for this specific compound. Dermal exposure from cosmetic use is expected to be low but measurable (fragrance ester), so exposure = 1. No data showing secretion in milk or specific lactation effects.
- p-cresyl isovalerate bebek cildi için güvenli mi?
- No infant‑specific toxicity or developmental studies found. Following instructions to increase exposure for infants when adult absorption is measurable, exposure is increased by +1 (adult e=1 → baby e=2) because infant skin has higher surface‑area‑to‑weight and immature barrier function. Hazard and mechanism remain 0 in absence of infant‑specific evidence.
- VeriMom p-cresyl isovalerate nasıl puanlıyor?
- VeriMom p-cresyl isovalerate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte p-cresyl isovalerate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.